Quantifying in-situ gas hydrates at active seep sites in the eastern Black Sea using pressure coring technique

In the eastern Black Sea, we determined methane (CH4) concentrations, gas hydrate volumes, and their vertical distribution from combined gas and chloride (Cl−) measurements within pressurized sediment cores. The total gas volume collected from the cores corresponded to concentrations of 1.2–1.4 mol CH4 kg−1 porewater at in-situ pressure, which is equivalent to a gas hydrate saturation of 15–18% of pore volume and amongst the highest values detected in shallow seep sediments. At the central seep site, a high-resolution Cl− profile resolved the upper boundary of gas hydrate occurrence and a continuous layer of hydrates in a sediment column of 120 cm thickness. Including this information, a more precise gas hydrate saturation of 22–24% pore volume could be calculated. This volume was higher in comparison to a saturation calculated from the Cl− profile alone, resulting in only 14.4%. The likely explanation is an active gas hydrate formation from CH4 gas ebullition. The hydrocarbons at Batumi Seep are of shallow biogenic origin (CH4 > 99.6%), at Pechori Mound they originate from deeper thermocatalytic processes as indicated by the lower ratios of C1 to C2–C3 and the presence of C5

Quantifying in-situ gas hydrates at active seep sites in the eastern

www.biogeosciences.net/8/3555/2011

cGMP-Dependent Protein Kinase I Is Crucial for Angiogenesis and Postnatal Vasculogenesis

Background Endothelium-derived nitric oxide plays an important role for the bone marrow microenvironment. Since several important effects of nitric oxide are mediated by cGMP-dependent pathways, we investigated the role of the cGMP downstream effector cGMP-dependent protein kinase I (cGKI) on postnatal neovascularization. Methodology/Principal Findings In a disc neovascularization model, cGKI -/- mice showed an impaired neovascularization as compared to their wild-type (WT) littermates. Infusion of WT, but not cGKI -/- bone marrow progenitors rescued the impaired ingrowth of new vessels in cGKI-deficient mice. Bone marrow progenitors from cGKI -/- mice showed reduced proliferation and survival rates. In addition, we used cGKI alpha leucine zipper mutant (LZM) mice as model for cGKI deficiency. LZM mice harbor a mutation in the cGKI alpha leucine zipper that prevents interaction with downstream signaling molecules. Consistently, LZM mice exhibited reduced numbers of vasculogenic progenitors and impaired neovascularization following hindlimb ischemia compared to WT mice. Conclusions/Significance Our findings demonstrate that the cGMP-cGKI pathway is critical for postnatal neovascularization and establish a new role for cGKI in vasculogenesis, which is mediated by bone marrow-derived progenitors

International ocean discovery program expedition 372 preliminary report: Creeping gas hydrate slides and Hikurangi LWD

International Ocean Discovery Program (IODP) Expedition 372 combined two research topics, slow slip events (SSEs) on subduction faults (IODP Proposal 781A-Full) and actively deforming gas hydrate-bearing landslides (IODP Proposal 841-APL). Our study area on the Hikurangi margin, east of the coast of New Zealand, provided unique locations for addressing both research topics.SSEs at subduction zones are an enigmatic form of creeping fault behavior. They typically occur on subduction zones at depths beyond the capabilities of ocean floor drilling. However, at the northern Hikurangi subduction margin they are among the best-documented and shallowest on Earth. Here, SSEs may extend close to the trench, where clastic and pelagic sediments about 1.0-1.5 km thick overlie the subducting, seamount-studded Hikurangi Plateau. Geodetic data show that these SSEs recur about every 2 years and are associated with measurable seafloor displacement. The northern Hikurangi subduction margin thus provides an excellent setting to use IODP capabilities to discern the mechanisms behind slow slip fault behaviour

High frequency VLBI observations of the scatter broadened quasar B2005+403

The quasar B2005+403 located behind the Cygnus region, is a suitable object for studying the interplay between propagation effects, which are extrinsic to the source and source intrinsic variability. On the basis of VLBI experiments performed at 1.6, 5, 8, 15, 22, and 43GHz between 1992-2003 and parallel multi-frequency monitoring of the total flux density, we investigated the variability of total flux density and source structure. Below 8 GHz, the point-like VLBI source is affected by scatter-broadening of the turbulent interstellar medium, which is located along the line of sight and likely associated with the Cygnus region. We present and discuss the measured frequency dependence of the source size, which shows a power-law with slope of -1.91+/-0.05. From the measured scattering angle at 1GHz of 77.1+/-4.0mas a SM=0.43+/-0.04 m^{-20/3} kpc is derived, consistent with the general properties of the ISM in this direction. The decreasing effect of angular broadening towards higher frequencies allows to study the internal structure of the source. Above 8GHz new VLBI observations reveal a one-sided slightly south-bending core-jet structure, with stationary and apparent superluminally moving jet components. The jet components move on non-ballistic trajectories. In AGN, total flux density variations are often related to the emergence of new VLBI components. However, during almost eleven years no new component was ejected in B2005+403. In the flux density variability a trough is observed at 5-37 GHz between 1996 and 2001. This can be explained as a blending effect of jet component fluxes. Dense in time sampled flux density monitoring observations reveal intra-day variability at 1.6GHz impling a second, less dense or turbulent scattering screen at few to hundred parsec distance.Comment: 18 pages, 9 figures, 8 tables, accepted for publication in Astronomy and Astrophysic

p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells

Patients treated with low-dose anthracyclines often show late onset cardiotoxicity. Recent studies suggest that this form of cardiotoxicity is the result of a progenitor cell disease. In this study we demonstrate that Cord Blood Endothelial Progenitor Cells (EPCs) exposed to low, sub-apoptotic doses of doxorubicin show a senescence phenotype characterized by increased SA-b-gal activity, decreased TRF2 and chromosomal abnormalities, enlarged cell shape, and disarrangement of F-actin stress fibers accompanied by impaired migratory ability. P16 INK4A localizes in the cytoplasm of doxorubicin-induced senescent EPCs and not in the nucleus as is the case in EPCs rendered senescent by different stimuli. This localization together with the presence of an arrest in G2, and not at the G1 phase boundary, which is what usually occurs in response to the cell cycle regulatory activity of p16INK4A, suggests that doxorubicin-induced p16 INK4A does not regulate the cell cycle, even though its increase is closely associated with senescence. The effects of doxorubicin are the result of the activation of MAPKs p38 and JNK which act antagonistically. JNK attenuates the senescence, p16 INK4A expression and cytoskeleton remodeling that are induced by activated p38. We also found that conditioned medium from doxorubicin-induced senescent cardiomyocytes does not attract untreated EPCs, unlike conditioned medium from apoptotic cardiomyocytes which has a strong chemoattractant capacity. In conclusion, this study provides a better understanding of the senescence of doxorubicin-treated EPCs, which may be helpful in preventing and treating late onset cardiotoxicity

Differential Modulation of Angiogenesis by Erythropoiesis-Stimulating Agents in a Mouse Model of Ischaemic Retinopathy

BACKGROUND: Erythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to promote pathological angiogenesis in some clinical scenarios. In the current study we have assessed the angiogenic potential of three ESAs; epoetin delta, darbepoetin alfa and epoetin beta using in vitro and in vivo models. METHODOLOGY/PRINCIPAL FINDINGS: The epoetins induced angiogenesis in human microvascular endothelial cells at high doses, although darbepoetin alfa was pro-angiogenic at low-doses (1-20 IU/ml). ESA-induced angiogenesis was VEGF-mediated. In a mouse model of ischaemia-induced retinopathy, all ESAs induced generation of reticulocytes but only epoetin beta exacerbated pathological (pre-retinal) neovascularisation in comparison to controls (p<0.05). Only epoetin delta induced a significant revascularisation response which enhanced normality of the vasculature (p<0.05). This was associated with mobilisation of haematopoietic stem cells and their localisation to the retinal vasculature. Darbepoetin alfa also increased the number of active microglia in the ischaemic retina relative to other ESAs (p<0.05). Darbepoetin alfa induced retinal TNFalpha and VEGF mRNA expression which were up to 4 fold higher than with epoetin delta (p<0.001). CONCLUSIONS: This study has implications for treatment of patients as there are clear differences in the angiogenic potential of the different ESAs

ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation

The work was supported by a grant A12008 from CR-UK (L. Dumartin, N.R. Lemoine and T. Crnogorac-Jurcevic)